Unité Cancéro-Dermatologie, Hôtel-Dieu CHU Nantes
Welcome,         Profile    Billing    Logout  
 5 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dreno, Brigitte
BECOME-MB, NCT04074096 / 2021-006331-26: Binimetinib Encorafenib Pembrolizumab +/- Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis

Active, not recruiting
2
10
Europe
Stereotaxic radiosurgery (SRS), Binimetinib Oral Tablet, Mektovi, Encorafenib Oral Capsule, Braftovi, Pembrolizumab, Keytruda
UNICANCER, European Association of Dermato Oncology, Pierre Fabre Medicament, Merck Sharp & Dohme LLC
Malignant Melanoma, BRAF V600 Mutation, Brain Metastases
04/25
04/29
RIC-Mel, NCT03315468: French Clinical Datbase of Melanoma Patients

Recruiting
N/A
16000
Europe
Nantes University Hospital, CENGEPS, Bristol-Myers Squibb, Hoffmann-La Roche, GlaxoSmithKline, Amgen
Melanoma (Skin)
03/30
03/30
MelBase, NCT02828202: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary

Recruiting
N/A
6000
Europe
Biological, Tissular, Quality of life
Assistance Publique - Hôpitaux de Paris, National Cancer Institute (NCI)
Malignant Melanoma
03/24
03/24
CARADERM, NCT03210935: French National Database of Rare Dermatological Cancers

Recruiting
N/A
9000
Europe
University Hospital, Lille
Adnexal Tumor of Skin, Merkel Cell Carcinoma, Advanced Basal Cell Carcinoma Requiring Systemic Treatment
12/25
12/25
COVER, NCT04352036: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the Cohort (Verneuil Cohort)

Recruiting
N/A
465
Europe
no interventional study
Nantes University Hospital
Acute Hidrosadenitis
02/30
02/30
COPACNE, NCT03465150: Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Recruiting
N/A
200
Europe
acne, acne vulgaris
Nantes University Hospital
Acne
02/33
12/33

Download Options